$343 Million is the total value of Eversept Partners, LP's 52 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 76.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ZGNX | Sell | ZOGENIX INC | $27,253,549 | +32.7% | 495,429 | -12.1% | 7.95% | -28.5% |
| AERI | Sell | AERIE PHARMACEUTICALS INC | $5,452,003 | -35.1% | 114,779 | -50.7% | 1.59% | -65.1% |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $3,394,572 | +7.1% | 75,721 | -6.9% | 0.99% | -42.3% |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $2,034,806 | +44.3% | 104,349 | -2.4% | 0.59% | -22.1% |
| AFMD | Sell | AFFIMED N V | $1,353,118 | +29.6% | 322,171 | -4.1% | 0.40% | -30.1% |
| CTRE | Sell | CARETRUST REIT INC | $976,632 | +2.1% | 41,264 | -19.5% | 0.28% | -45.0% |
| CFMS | Exit | CONFORMIS INC | $0 | – | -136,851 | -100.0% | -0.03% | – |
| EPZM | Exit | EPIZYME INC | $0 | – | -25,449 | -100.0% | -0.08% | – |
| OPNT | Exit | OPIANT PHARMACEUTICALS INC | $0 | – | -13,901 | -100.0% | -0.11% | – |
| SPNE | Exit | SEASPINE HLDGS CORP | $0 | – | -15,459 | -100.0% | -0.15% | – |
| FLDM | Exit | FLUIDIGM CORP DEL | $0 | – | -50,455 | -100.0% | -0.24% | – |
| NTRA | Exit | NATERA INC | $0 | – | -39,539 | -100.0% | -0.30% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INC | $0 | – | -62,750 | -100.0% | -0.33% | – |
| ANTM | Exit | ANTHEM INC | $0 | – | -2,300 | -100.0% | -0.33% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -8,271 | -100.0% | -0.43% | – |
| PBYI | Exit | PUMA BIOTECHNOLOGY INC | $0 | – | -42,301 | -100.0% | -0.47% | – |
| BSTC | Exit | BIOSPECIFICS TECHNOLOGIES CO | $0 | – | -22,000 | -100.0% | -0.72% | – |
| LOXO | Exit | LOXO ONCOLOGY INC | $0 | – | -10,000 | -100.0% | -0.76% | – |
| MYL | Exit | MYLAN N V | $0 | – | -55,000 | -100.0% | -0.82% | – |
| GHDX | Exit | GENOMIC HEALTH INC | $0 | – | -23,866 | -100.0% | -0.83% | – |
| ILMN | Exit | ILLUMINA INC | $0 | – | -5,148 | -100.0% | -0.84% | – |
| QGEN | Exit | QIAGEN NV | $0 | – | -55,300 | -100.0% | -1.03% | – |
| ABT | Exit | ABBOTT LABS | $0 | – | -31,400 | -100.0% | -1.23% | – |
| TSRO | Exit | TESARO INC | $0 | – | -36,000 | -100.0% | -1.45% | – |
| MRK | Exit | MERCK & CO INC | $0 | – | -45,800 | -100.0% | -1.91% | – |
| MYL | Exit | MYLAN N Vcall | $0 | – | -158,600 | -100.0% | -2.35% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-11-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMARIN CORP PLC | 21 | Q3 2023 | 12.5% |
| DANAHER CORPORATION | 21 | Q3 2023 | 8.1% |
| AFFIMED N V | 20 | Q3 2023 | 0.9% |
| ARGENX SE | 19 | Q3 2023 | 2.0% |
| GSK PLC | 18 | Q2 2022 | 13.1% |
| ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
| SANOFI | 18 | Q4 2022 | 7.2% |
| ENSIGN GROUP INC | 18 | Q1 2022 | 8.6% |
| CENTENE CORP DEL | 18 | Q3 2023 | 1.5% |
| ZOGENIX INC | 17 | Q4 2021 | 12.4% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
| Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.